Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.9%
- Check13 days agoChange DetectedThe page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed from the content.SummaryDifference1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference1%
Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.